An HIV Vaccine: An Unfulfilled Promise—Episode 2, Learning Through Failing
Listen to Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.
Decera Clinical Education Infectious Disease Podcast · Jontraye Davis, Susan Buchbinder MD, Jerome H Kim MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.
Presenters:
Susan Buchbinder, MD
Clinical Professor
Departments of Medicine, Epidemiology and Biostatistics
University of California, San Francisco
Director, Bridge HIV
San Francisco Department of Public Health
San Francisco, California
Jontraye Davis, MHA, PMD Pro
Community Program Manager
FHI 360
Adjunct Instructor
North Carolina Central University
Durham, North Carolina
Special Commentator:
Jerome H. Kim, MD
Director General
International Vaccine Institute
Seoul, South Korea
Link to full series:
https://bit.ly/3ytytMY
Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d
Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.